ARTICLE | Company News
Nexell gene/cell therapy news
May 20, 2002 7:00 AM UTC
NEXL said it will reduce its headcount to 3 from 23 and may liquidate, reorganize or dissolve. NEXL said its decision was based on its inability to raise capital or forge partnerships with other compa...